Stock CL CRESCO LABS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Cresco Labs Inc.

Equities

CL

CA22587M1068

Pharmaceuticals

Market Closed - Canadian Securities Exchange
Other stock markets
 03:59:59 2024-06-14 pm EDT 		5-day change 1st Jan Change
2.22 CAD -5.13% Intraday chart for Cresco Labs Inc. -7.50% +24.02%
May. 16 Cresco Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 15 Transcript : Cresco Labs Inc., Q1 2024 Earnings Call, May 15, 2024

Business Summary

Cresco Labs Inc. is an integrated multi-state cannabis operator in the United States. The Company is licensed to cultivate, manufacture, and sell retail and medical cannabis products primarily through Sunnyside, Cresco Labs’ national dispensary brand, and third-party retail stores. Its family brands include Cresco, High Supply, Good News, Wonder Wellness Co., FloraCal Farms, Remedi and Mindy’s. Its portfolio consists of over 400 products. The Company's products are sold in over 1,600 dispensaries across the country. Its Cresco offers consistent strains, available in a variety of product forms at dispensaries and retail locations nationwide. Its High Supply lab-tested; and available in vape carts, vape pens, flower, popcorn, shake, shorties and concentrates. Its Remedi products provide a consistent and trusted alternative to traditional pharmaceuticals like opioids. Its Mindy’s offers dosed edibles created by James Beard. It is the wholesaler of branded cannabis products.

Number of employees: 2,800

Sales per Business

CAD in Million2022Weight2023Weight Delta
Dispensary
60.3 %
- - 627 60.3 % -
Wholesale
39.7 %
- - 413 39.7 % -

Sales per region

CAD in Million2022Weight2023Weight Delta
United States
100.0 %
1,097 100.0 % 1,040 100.0 % -5.16%

Managers

Managers TitleAgeSince
Charles Bachtell FOU
 Founder 45 15-01-31
Gregory Butler PSD
 President 44 -
Dennis Olis DFI
 Director of Finance/CFO 61 20-06-30
Ty Gent COO
 Chief Operating Officer 64 21-01-18
Zach Marburger CTO
 Chief Tech/Sci/R&D Officer 38 15-08-31
Megan W. Kulick IRC
 Investor Relations Contact - -
Angie Demchenko HRO
 Human Resources Officer 43 19-07-16
John Schetz LAW
 General Counsel 47 18-05-31

Members of the board

Members of the board TitleAgeSince
John Walter BRD
 Director/Board Member 76 17-02-28
Carol Vallone BRD
 Director/Board Member 67 -
Thomas Joseph Manning CHM
 Chairman 68 12-12-31
Gerald Corcoran BRD
 Director/Board Member 69 17-02-28
Marc Lustig BRD
 Director/Board Member 51 20-06-28
Michele Roberts BRD
 Director/Board Member 67 20-06-09
Charles Bachtell FOU
 Founder 45 15-01-31
Randy Podolsky BRD
 Director/Board Member 68 16-11-30
Robert Sampson FOU
 Founder 49 90-07-05
Tarik Brooks BRD
 Director/Board Member 48 21-04-21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 17,781,000 0 0 73.73 %
Stock B 0 500,000 0 0
Stock C 0 95,505,000 0 0
Stock D 1 328,586,651 326,156,808 ( 99.26 %) 0

Shareholders

NameEquities%Valuation
Charles Bachtell
0.2558 %
829,886 0.2558 % 2 M $
Zach Marburger
0.1768 %
573,536 0.1768 % 1 M $
Robert Sampson
0.1715 %
556,231 0.1715 % 1 M $
Gerald Corcoran
0.1223 %
396,841 0.1223 % 757 966 $
Dominic Sergi
0.0899 %
291,564 0.0899 % 556 887 $
Jason Bennett Erkes
0.0866 %
280,969 0.0866 % 536 651 $
John Schetz
0.0655 %
212,554 0.0655 % 405 978 $
Dennis Olis
0.0608 %
197,236 0.0608 % 376 721 $
Randy Podolsky
0.0537 %
174,046 0.0537 % 332 428 $
Purpose Investments, Inc.
0.0432 %
140,000 0.0432 % 267 400 $
NameEquities%Valuation
Charles Bachtell
4.038 %
5,313 4.038 % 10 148 $
John Walter
0.8946 %
1,177 0.8946 % 2 248 $
Thomas Joseph Manning
0.3800 %
500 0.3800 % 955 $
Robert Sampson
0.003040 %
4 0.003040 % 8 $
NameEquities%Valuation
Marc Lustig
99.94 %
1,589 99.94 % 3 035 $
NameEquities%Valuation
Charles Bachtell
9.120 %
13,102,342 9.120 % 25 M $
Robert Sampson
7.727 %
11,101,049 7.727 % 21 M $
Randy Podolsky
0.5669 %
814,387 0.5669 % 2 M $
Gerald Corcoran
0.5202 %
747,395 0.5202 % 1 M $
NameEquities%Valuation
Thomas Joseph Manning
26.75 %
133,760 26.75 % 255 482 $
Robert Sampson
26.66 %
133,308 26.66 % 254 618 $
Charles Bachtell
26.59 %
132,932 26.59 % 253 900 $
Brian McCormack
20.00 %
100,000 20.00 % 191 000 $

Company contact information

Cresco Labs, Inc.

400 West Erie Street Suite 110

60654, Chicago

+312 410 8226

http://www.crescolabs.com
address Cresco Labs Inc.(CL)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Cresco Labs Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1.608 USD
Average target price
4.652 USD
Spread / Average Target
+189.37%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CRESCO LABS INC. Stock Cresco Labs Inc.
+24.02% 565M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.96% 630B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.15% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.77% 328B
ABBVIE INC. Stock AbbVie Inc.
+8.79% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.02% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+1.27% 225B
NOVARTIS AG Stock Novartis AG
+11.95% 218B
AMGEN INC. Stock Amgen Inc.
+3.68% 160B
PFIZER, INC. Stock Pfizer, Inc.
-4.38% 156B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. CL Stock
  4. Company Cresco Labs Inc.